Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
6.61
+0.23 (3.61%)
At close: May 15, 2025, 4:00 PM
6.59
-0.02 (-0.30%)
After-hours: May 15, 2025, 4:42 PM EDT
Sage Therapeutics Market Cap
Sage Therapeutics has a market cap or net worth of $413.92 million as of May 15, 2025. Its market cap has decreased by -51.50% in one year.
Market Cap
413.92M
Enterprise Value
1.92M
1-Year Change
-51.50%
Ranking
Category
Stock Price
$6.61
Market Cap Chart
Since July 18, 2014, Sage Therapeutics's market cap has decreased from $751.40M to $413.92M, a decrease of -44.91%. That is a compound annual growth rate of -5.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 399.50M | 20.26% |
| Dec 31, 2024 | 332.20M | -74.44% |
| Dec 29, 2023 | 1.30B | -42.73% |
| Dec 30, 2022 | 2.27B | -9.45% |
| Dec 31, 2021 | 2.51B | -44.34% |
| Dec 31, 2020 | 4.50B | 20.36% |
| Dec 31, 2019 | 3.74B | -16.71% |
| Dec 31, 2018 | 4.49B | -27.36% |
| Dec 29, 2017 | 6.18B | 225.79% |
| Dec 30, 2016 | 1.90B | 12.78% |
| Dec 31, 2015 | 1.68B | 78.25% |
| Dec 31, 2014 | 944.00M | 25.63% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.99B |
| Johnson & Johnson | 358.22B |
| AbbVie | 317.67B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 241.20B |
| Abbott Laboratories | 231.00B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |